Sales decline 50.00% to Rs 0.05 crore
Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against net loss of Rs 0.13 crore during the previous quarter ended June 2023. Sales declined 50.00% to Rs 0.05 crore in the quarter ended June 2024 as against Rs 0.10 crore during the previous quarter ended June 2023.
ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales0.050.10 -50 OPM %-820.00-120.00 –PBDT0.22-0.11 LP PBT0.20-0.13 LP NP0.20-0.13 LP
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 12 2024 | 11:58 AM IST
